Line 172: | Line 172: | ||
<div id="words" style="float:right;width:70%"> | <div id="words" style="float:right;width:70%"> | ||
<div class="row text-center"> | <div class="row text-center"> | ||
− | <h2><br><br><br><br><br><br><br> | + | <h2><br><br><br><br><br><br><br>Basic Part</h2> |
<center><hr width="70%" align="center" color="#c91f77" size=1;></hr></center> | <center><hr width="70%" align="center" color="#c91f77" size=1;></hr></center> | ||
</div> | </div> | ||
<div class="indent"> | <div class="indent"> | ||
− | + | <br><br> | |
− | + | <img src="https://static.igem.org/mediawiki/2016/6/65/BIT_basic_part.jpg" class="img-responsive" alt="..."> | |
− | + | <br> | |
− | + | <p><b>miRNA-155 binding site</b></p> | |
− | + | <br> | |
− | + | <p> MiRNAs are widely recognized as biomarkers of many diseases. Many studies have shown that, miRNA-155 in patients with breast cancer in the body was significantly higher than normal people. After a thorough literature review , we know the recognition site of miRNA-155, of which the transcription product, mRNA and miRNA-155 base-specific complementary matching, in order to increase its binding specificity with miRNA-155, we design four binding sites for this part, so that when the miRNA-155 presence, it can be quickly identified by this fragment and combine to form double-stranded mRNA complex, blocking the binding of ribosomes, which will inhibit the downstream gene expression, which is called RNA-based gene silencing expression. This can serve as a switch to regulate the expression of downstream genes. | |
− | + | </p> | |
− | + | <br><br><br><br><br> | |
− | < | + | |
− | < | + | |
− | + | ||
− | </p> | + | |
− | + | ||
− | + | ||
− | < | + | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | </p> | + | |
− | + | ||
− | + | ||
− | + | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 17:10, 19 October 2016
<!DOCTYPE html>
Basic Part
miRNA-155 binding site
MiRNAs are widely recognized as biomarkers of many diseases. Many studies have shown that, miRNA-155 in patients with breast cancer in the body was significantly higher than normal people. After a thorough literature review , we know the recognition site of miRNA-155, of which the transcription product, mRNA and miRNA-155 base-specific complementary matching, in order to increase its binding specificity with miRNA-155, we design four binding sites for this part, so that when the miRNA-155 presence, it can be quickly identified by this fragment and combine to form double-stranded mRNA complex, blocking the binding of ribosomes, which will inhibit the downstream gene expression, which is called RNA-based gene silencing expression. This can serve as a switch to regulate the expression of downstream genes.
Contact Us
Beijing Institute of Technology,
No. 5 South Zhong Guan Cun Street,
Haidian Beijing 100081, P. R. China
Twitter : @igem_BIT
Sina Weibo : @igem_BIT
Website : http://www.bit.edu.cn